Acute upper respiratory tract infection
Conditions
Interventions
control group:none
Test group:On the basis of the control group Chaiyin granules (drug approval number: National Medical Products Administration Approval No. Z20050338 Lunan Houpu Pharmaceutical Co. Ltd. 8g/bag 1 bag ta
Sponsors
Changxing People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: If the answer to any of the following questions is' no ' the case cannot be included in this study. (1) Age range of 18-65 years old (including 18 and 65 years old) gender is not limited; (2) Meets the diagnostic criteria of the Primary Diagnosis and Treatment Guidelines for Acute Upper Respiratory Infections (2018); (3) Within 48 hours of onset; (4) The patient agrees to sign an informed consent form.
Exclusion criteria
Exclusion criteria: If the answer to any of the following questions is "yes" the case cannot be included in this study. (1) Patients with a recent history of taking hormones heat clearing and detoxifying drugs; (2) Suffering from immune system diseases; (3) Combined with severe organ dysfunction diseases; (4) Individuals with respiratory deformities; (5) Allergic reactions to drugs; (6) Suffering from mental disorders; (7) Pregnant or lactating women; (8) Those who stop taking medication midway; (9) Patients with incomplete clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sore throat;cough;dizzy;fever; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions; | — |
Countries
China
Contacts
Public ContactMeicheng Sun
Changxing People's Hospital
Outcome results
None listed